LH Laboratory Corp Of America Holdings

Price (delayed)

$252.21

Market cap

$22.35B

P/E Ratio

13.36

Dividend/share

$2.15

EPS

$18.88

Enterprise value

$28.21B

Laboratory Corporation of America Holdings, more commonly known as LabCorp, is an American S&P 500 company headquartered in Burlington, North Carolina. It operates one of the largest clinical laboratory networks ...

Highlights
The price to earnings (P/E) is 22% lower than the 5-year quarterly average of 17.3 but 15% higher than the last 4 quarters average of 11.7
LH's net income is down by 36% YoY and by 12% from the previous quarter
Laboratory Corp Of America Holdings's EPS has decreased by 34% YoY and by 10% QoQ

Key stats

What are the main financial stats of LH
Market
Shares outstanding
88.6M
Market cap
$22.35B
Enterprise value
$28.21B
Valuations
Price to earnings (P/E)
13.36
Price to book (P/B)
2.26
Price to sales (P/S)
1.49
EV/EBIT
11.77
EV/EBITDA
8.66
EV/Sales
1.85
Earnings
Revenue
$15.26B
EBIT
$2.4B
EBITDA
$3.26B
Free cash flow
$1.49B
Per share
EPS
$18.88
Free cash flow per share
$16.44
Book value per share
$111.64
Revenue per share
$168.79
TBVPS
$86.29
Balance sheet
Total assets
$19.83B
Total liabilities
$9.71B
Debt
$6.27B
Equity
$10.09B
Working capital
$1.85B
Liquidity
Debt to equity
0.62
Current ratio
1.73
Quick ratio
1.35
Net debt/EBITDA
1.8
Margins
EBITDA margin
21.3%
Gross margin
31.4%
Net margin
11.5%
Operating margin
15.8%
Efficiency
Return on assets
8.6%
Return on equity
16.9%
Return on invested capital
21.8%
Return on capital employed
13.8%
Return on sales
15.7%
Dividend
Dividend yield
0.85%
DPS
$2.15
Payout ratio
11.4%

LH stock price

How has the Laboratory Corp Of America Holdings stock price performed over time
Intraday
-0.82%
1 week
-2.18%
1 month
7.1%
1 year
-6.62%
YTD
7.1%
QTD
7.1%

Financial performance

How have Laboratory Corp Of America Holdings's revenue and profit performed over time
Revenue
$15.26B
Gross profit
$4.79B
Operating income
$2.41B
Net income
$1.76B
Gross margin
31.4%
Net margin
11.5%
Laboratory Corp Of America Holdings's operating income has decreased by 37% YoY and by 11% QoQ
LH's net income is down by 36% YoY and by 12% from the previous quarter
The operating margin has contracted by 32% YoY and by 9% from the previous quarter
The net margin has declined by 31% year-on-year and by 9% since the previous quarter

Growth

What is Laboratory Corp Of America Holdings's growth rate over time

Valuation

What is Laboratory Corp Of America Holdings stock price valuation
P/E
13.36
P/B
2.26
P/S
1.49
EV/EBIT
11.77
EV/EBITDA
8.66
EV/Sales
1.85
Laboratory Corp Of America Holdings's EPS has decreased by 34% YoY and by 10% QoQ
The price to earnings (P/E) is 22% lower than the 5-year quarterly average of 17.3 but 15% higher than the last 4 quarters average of 11.7
The company's equity fell by 4.1% YoY and by 3% QoQ
LH's revenue is down by 8% year-on-year and by 2.9% since the previous quarter

Efficiency

How efficient is Laboratory Corp Of America Holdings business performance
The company's return on invested capital fell by 41% YoY and by 13% QoQ
LH's ROE is down by 39% YoY and by 11% QoQ
LH's ROA is down by 36% YoY and by 11% QoQ
Laboratory Corp Of America Holdings's return on sales has decreased by 33% YoY and by 10% QoQ

Dividends

What is LH's dividend
DPS
$2.15
Dividend yield
0.85%
Payout ratio
11.4%

Financial health

How did Laboratory Corp Of America Holdings financials performed over time
LH's total assets is 104% greater than its total liabilities
The quick ratio has contracted by 23% YoY and by 13% from the previous quarter
Laboratory Corp Of America Holdings's current ratio has decreased by 17% YoY and by 9% from the previous quarter
The debt is 38% smaller than the equity
The company's equity fell by 4.1% YoY and by 3% QoQ
LH's debt to equity is up by 3.3% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.